JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2025. Vol. 70. № 5
DOI:10.33266/1024-6177-2025-70-5-11-17
E.A. Mysina, D.D. Kolmanovich, N.R. Popova, B.A. Bokl,
N.A. Pivovarov, N.N. Chukavin, I.V. Savintseva, D.A. Vinnik, A.L. Popov
3D Cell Spheroid as a Relevant Experimental Model for Screening Potential Nanoradiosensitizers
Institute of Theoretical and Experimental Biophysics, Pushchino, Russia
Contact person: A.L. Popov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: Cell monolayer (2D culture) has been used to screen biological activity of various biomolecules, nanoconjugates, and other therapeutic agents. However, 2D cell culture cannot fully imitate real physiological structures and states of the human body, in particular, the organization and microenvironment of a solid tumor. This imposes significant limitations on current translational studies of the biological effect of new therapeutic drugs and approaches to tumor radiation therapy. To overcome these limitations, models based on 3D cell spheroids are developed and put into practice. These models allow the most reliable imitation of the structure and state of a solid tumor, including the formation of 3D intercellular matrix, characteristic zonation, and corresponding gene expression.
Purpose of the investigation: To create an experimental model of a 3D spheroid formed on the basis of mouse breast cancer cells EMT6/P line and validate the model under X-ray exposure for screening potential nanoradiosensitizers.
Material and methods: The EMT6/P cell line (mouse carcinoma) was used to form a 3D cell spheroid and evaluate the biological effect of X-ray radiation on it. Cell spheroids were prepared using the "hanging drop" method. An RUT-15 X-ray machine was used to irradiate the spheroids. The radiation doses varied from 0 to 10 Gy. After irradiation, cell viability was analyzed by flow cytometry. Staining was performed with a set of fluorescent dyes Annexin V-FITC/propidium iodide. The migration activity of irradiated spheroid cells was assessed by confluent analysis after transferring the spheroid to adhesive plastic.
Results: A dose-dependent decrease in cell migration activity was shown after X-ray irradiation in the dose range of 1–10 Gy. It has been established that doses of 6–8 Gy are optimal for the analysis of potential radiosensitizers by assessing the migration activity of cells. Using citrate-stabilized cerium oxide (CeO2) nanoparticles as an example, the possibility of using this model for rapid screening of nanomaterials with radiosensitizing action is demonstrated.
Conclusion: A method for forming 3D cell spheroids from EMT6/P cells has been developed and validated. The optimal dose of X-ray irradiation of the resulting cell spheroid has been selected for rapid screening of potential radiosensitizers. The functionality and reproducibility of the developed experimental model have been confirmed.
Keywords: 3D cell spheroid, solid tumor model, X-ray irradiation, radiosensitization
For citation: Mysina EA, Kolmanovich DD, Popova NR, Bokl BA, Pivovarov NA, Chukavin NN, Savintseva IV, Vinnik DA, Popov AL. 3D Cell Spheroid as a Relevant Experimental Model for Screening Potential Nanoradiosensitizers. Medical Radiology and Radiation Safety. 2025;70(5):11–17. (In Russian). DOI:10.33266/1024-6177-2025-70-5-11-17
References
1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. A Cancer Journal for Clinicians. 2021. Vol. 71. Global Cancer Statistics 2020;3:209-249.
2. Kapałczyńska M., Kolenda T., Przybyła W., Zajączkowska M., Teresiak A., Filas V., Ibbs M., Bliźniak R., Łuczewski Ł., Lamperska K. 2D and 3D Cell Cultures - a Comparison of Different Types of Cancer Cell Cultures. Archives of Medical Science: AMS. 2018;14;4:910-919.
3. Zhang C., Sui Y., Liu S., Yang M. In Vitro and in Vivo Experimental Models for Cancer Immunotherapy Study. Current Research in Biotechnology. 2024;7:100210.
4. Baker B.M., Chen C.S. Deconstructing the Third Dimension ‒ How 3D Culture Microenvironments Alter Cellular Cues. Journal of Cell Science. 2012;125;13:3015-24. doi: 10.1242/jcs.079509.
5. Gunti S., Hoke A.T.K., Vu K.P., London N.R. Organoid and Spheroid Tumor Models: Techniques and Applications. Cancers. 2021;13;4:874. doi: 10.3390/cancers13040874
6. Rofstad E.K. Growth and Radiosensitivity of Malignant Melanoma Multicellular Spheroids Initiated Directly from Surgical Specimens of Tumours in Man. British Journal of Cancer. 1987; 54;4:569-578.
7. Rofstad E.K., Wahl A., Brustad T. Radiation Response of Human Melanoma Multicellular Spheroids Measured as Single Cell Survival, Growth Delay, and Spheroid Cure: Comparisons with the Parent Tumor Xenograft. International Journal of Radiation Oncology*Biology*Physics. 1986;
12;6:975-982.
8. Wheldon T.E., Livingstone A., Wilson L., O’Donoghue J., Gregor A. The Radiosensitivity of Human Neuroblastoma Cells Estimated from Regrowth Curves of Multicellular Tumour Spheroids. The British Journal of Radiology. 1985;58;691:661-664.
9. Wei Q., Xu W., Han M., Dong Q., Fu Z., Diao, Liu H., Xu J., Jiang H., Zheng S., Gao J.-Q., Jiang H. Doxorubicin-Mediated Radiosensitivity in Multicellular Spheroids from a Lung Cancer Cell Line is Enhanced by Composite Micelle Encapsulation. International Journal of Nanomedicine. 2012;7:2661-2671.
10. Brüningk S.C., Rivens I., Box C., Oelfke U., Ter Haar G. 3D Tumour Spheroids for the Prediction of the Effects of Radiation and Hyperthermia Treatments. Scientific Reports. 2020;10;1:1653.
11. Bromma K., Beckham W., Chithrani D.B. Utilizing Two-Dimensional Monolayer and Three-Dimensional Spheroids to Enhance Radiotherapeutic Potential by Combining Gold Nanoparticles and Docetaxel. Cancer Nanotechnology. 2023;14;1:80.
12. Higashi Y., Matsumoto K., Saitoh H., Shiro A., Ma Y., Laird M., Chinnathambi S., Birault A., Doan T.L.H., Yasuda R., Tajima T., Kawachi T., Tamanoi F. Iodine Containing Porous Organosilica Nanoparticles Trigger Tumor Spheroids Destruction Upon Monochromatic X-Ray Irradiation: DNA Breaks and K-Edge Energy X-Ray. Scientific Reports. 2021;11;1:14192.
13. Tang J.L.Y., Moonshi S.S., Ta H.T. Nanoceria: an Innovative Strategy for Cancer Treatment. Cellular and Molecular Life Sciences: CMLS. 2023;80;2:46.
14. Ivanova O.S., Shekunova T.O., Ivanov V.K., Shcherbakov A.B., Popov A.L., Davydova G.A., Selezneva I.I., Kopitsa G.P., Tret’yakov Yu.D. One-Stage Synthesis of Ceria Colloid Solutions for Biomedical Use. Doklady Chemistry. 2011;437;2:103-106.
15. Li Y.Q., Guo Y.P., Jay V., Stewart P.A., Wong C.S. Time Course of Radiation-Induced Apoptosis in the Adult Rat Spinal Cord. Radiotherapy and Oncology. 1996;39;1:35-42.
16. Zamyatina E.A., Goryacheva O.A., Popov A.L., Popova N.R. Novel Pyrroloquinoline Quinone-Modified Cerium Oxide Nanoparticles and Their Selective Cytotoxicity Under X-Ray Irradiation. Antioxidants. 2024;13;12:1445.
17. Mysina E., Vinnik D., Pivovarov N., Popova N., Chukavin N., Popov A. Nanoceria Inhibit the Cell Migration from 3D Tumor Spheroid Formed From 4T1 Human Breast Cancer Cells. Biology and Life Sciences, 2025;16;2 (Print).
18. Hirschhaeuser F., Menne H., Dittfeld C., West J., Mueller-Klieser W., Kunz-Schughart L.A. Multicellular Tumor Spheroids: An Underestimated Tool is Catching up Again. Journal of Biotechnology. 2010;148;1:3-15.
19. Wojtkowiak J.W., Verduzco D., Schramm K.J., Gillies R.J. Drug Resistance and Cellular Adaptation to Tumor Acidic PH Microenvironment. Molecular Pharmaceutics. 2011;8;6:2032-2038.
20. West C.M., Sutherland R.M. The Radiation Response of a Human Colon Adenocarcinoma Grown in Monolayer, as Spheroids, and in Nude Mice. Radiation Research. 1987;112;1:105-115.
21. Schwachöfer J.H.M., Hoogenhout J., Kal H.B. The Radiation Response of a Human Lung Adenocarcinoma Grown in Monolayer, as Spheroids, and in Nude Mice. Lung Cancer. 1991;7;4:213-223.
22. Kornienko A.I., Teplonogova M.A., Shevelyova M.P., Popkov M.A., Popov A.L., Ivanov V.E., Popova N.R. Novel Flavin Mononucleotide-Functionalized Cerium Fluoride Nanoparticles for Selective Enhanced X-Ray-Induced Photodynamic Therapy. Journal of Functional Biomaterials. 2024;15;12:373.
23. Kolmanovich D.D., Romanov M.V., Khaustov S.A., Ivanov V.K., Shemyakov A.E., Chukavin N.N., Popov A.L. Proton Beam-Induced Radiosensitizing Effect of Ce0.8Gd0.2O2-x Nanoparticles Against Melanoma Cells in Vitro. Nanosystems: Physics, Chemistry, Mathematics. 2024;15;5:675-682.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The article was prepared as part of the RSCF grant No 22-73-10231, https://rscf.ru/project/22-73-10231/.
Contribution. E.A. Mysina – work with spheroids (cultivation, irradiation, viability analysis), D.D. Kolmanovich – flow cytometry and data analysis, N.R. Popova – scientific text editing, B.A. Bokle – collection and analysis of literary material, N.A. Pivovarov– collection and analysis of literary material, N.N. Chukavin – scientific text editing, I.V. Savintseva– cell culture, D.A. Vinnik – spheroid irradiation, A.L. Popov – research design development, scientific guidance.
Article received: 20.05.2025. Accepted for publication: 25.06.2025.